Cidara Therapeutics Inc. (NASDAQ: CDTX)
$12.82
+0.3200 ( +2.56% ) 25.9K
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
Market Data
Open
$12.82
Previous close
$12.50
Volume
25.9K
Market cap
$59.03M
Day range
$12.18 - $13.06
52 week range
$10.00 - $24.40
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 11, 2024 |
ars | Annual reports | 1 | Jun 03, 2024 |
def | Proxies and info statements | 8 | Jun 03, 2024 |
pre | Proxies and info statements | 4 | May 23, 2024 |
8-k | 8K-related | 13 | May 20, 2024 |
8-k | 8K-related | 15 | May 15, 2024 |
10-q | Quarterly Reports | 74 | May 15, 2024 |
8-k | 8K-related | 77 | May 03, 2024 |
3 | Insider transactions | 1 | Apr 30, 2024 |
4 | Insider transactions | 1 | Apr 30, 2024 |